EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria

Ijeoma M Ifeorah iD, Jonadab Chinwendu iD, Stanley C Eneh iD, Babayemi O Olakunde, Uduak Akpan, Nicholas A Awolola, Uwem E George iD, Temitope O C Faleye, Popoola Bolutife, Chukwuma E Omoruyi, Chinonso C Iyi, Carey Tishiya und 6 weitere

PLOS One · 10.11.2026 · 21 (11) · e0360438

DOI: 10.1371/journal.pone.0360438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 10.11.2026. Verfasst von Ijeoma M Ifeorah und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Enugu Campus, Enugu, Nigeria. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Human Papillomavirus Viruses. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Association for Cancer Research, Beginning Investigator Grant for Catalytic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women living with HIV (WLHIV) are at significantly higher risk of persistent high-risk human papillomavirus (hrHPV), and consequently, cervical cancer. However, large scale data on the epidemiology of hrHPV genotypes among WLHIV are limited in Nigeria. The study aimed to determine the prevalence and distribution of hrHPV among WLHIV in Nigeria. We conducted a cross-sectional study among 1327 WLHIV aged 25−60 years receiving HIV care from six selected Nigeria Implementation Science Alliance–Model Innovation and Research Centers (NISA-MIRCs) across Nigeria. Cervical swabs were obtained, and HPV DNA genotype was determined using the Hybribio Genoarray assay that detects 37 HPV genotypes including 14 high-risk HPVs. Sociodemographic and clinical data were collected using interviewer-administered structured questionnaire. Factors independently associated with hrHPV infection were identified using multivariable logistic regression. Statistical analysis was performed using R statistical software (version 4.4.1) with significance set at p < 0.05. Among the 1105 participants with analyzable samples, the overall HPV and hrHPV prevalence were 30.9% and 22.1%, respectively, with regional differences. Non-HPV 16 and 18 accounted for nearly two-thirds (67.6%) of hrHPV infections. The top five most often detected hrHPVs were HPV-58 (14.2%), HPV-16 (12.7%), HPV-52 (12.4%), HPV-31 (10.6%), and HPV-18 (10.3%). In a multivariate analysis, ART usage for one year or less was associated with hrHPV infection (aOR = 8.2, 95% CI 4.3–16.0). This multi-site study showed a significant and genotype-diverse burden of hrHPV among HIV-positive women in Nigeria, with most infections caused by non-HPV16/18 variants. These findings emphasize the need for increased integration of cervical cancer screening within HIV care and support the call for HPV vaccines with broader genotype coverage beyond HPV 16 and 18 to address the prevailing genotype distribution in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHIV InfectionsHuman Papillomavirus VirusesHumansFemaleNigeriaGenotypePrevalenceAdultMiddle AgedCross-Sectional StudiesRisk Factors

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Enugu Campus, Enugu, Nigeria.
  • Vaccine Research Center, University of Nigeria, Enugu, Nigeria.
  • IVAN Research Institute, University of Nigeria, Enugu, Nigeria.
  • Interdisciplinary Health Sciences, University of Texas at El Paso, El Paso, Texas, United States of America.
  • Department of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
  • Excellence Community Education Welfare Scheme (ECEWS), Abuja, Nigeria.

ORCID-Profile: Ijeoma M Ifeorah, Jonadab Chinwendu, Stanley C Eneh, Uwem E George, Emo A Ivo, Olubusuyi M Adewumi

Förderung

  • American Association for Cancer Research
  • Beginning Investigator Grant for Catalytic Research

Zitieren

APA

Ifeorah, I. M., Chinwendu, J., Eneh, S. C., Olakunde, B. O., Akpan, U., Awolola, N. A., George, U. E., Faleye, T. O. C., Bolutife, P., Omoruyi, C. E., Iyi, C. C., Tishiya, C., Ivo, E. A., Banjo, A. A. F., Chigbu, C. O., Hou, L., Ezeanolue, E. E., & Adewumi, O. M. (2026). Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria. PLOS One, 21(11), e0360438. https://doi.org/10.1371/journal.pone.0360438

Vancouver

Ifeorah IM, Chinwendu J, Eneh SC, Olakunde BO, Akpan U, Awolola NA, et al. Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria. PLOS One. 2026;21(11):e0360438. doi:10.1371/journal.pone.0360438

BibTeX
@article{Ifeorah2026,
  author = {Ifeorah, Ijeoma M and Chinwendu, Jonadab and Eneh, Stanley C and Olakunde, Babayemi O and Akpan, Uduak and Awolola, Nicholas A and George, Uwem E and Faleye, Temitope O C and Bolutife, Popoola and Omoruyi, Chukwuma E and Iyi, Chinonso C and Tishiya, Carey and Ivo, Emo A and Banjo, Adekunbiola A F and Chigbu, Chibuike O and Hou, Lifang and Ezeanolue, Echezona E and Adewumi, Olubusuyi M},
  title = {Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0360438},
  doi = {10.1371/journal.pone.0360438}
}
Kostenlos starten →